<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03544151</url>
  </required_header>
  <id_info>
    <org_study_id>2018-012</org_study_id>
    <nct_id>NCT03544151</nct_id>
  </id_info>
  <brief_title>Swan-Ganz CCOmbo V for Obtaining an Optimal Depth of Right Internal Jugular Venous Catheter</brief_title>
  <official_title>Swan-Ganz CCOmbo V for Obtaining an Optimal Depth of Right Internal Jugular Venous Catheter : A Prospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will perform a study to create formula for the optimal insertion depth of
      right internal jugular vein catheter.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients scheduled for cardiac surgery were studied.Determine the optimal insertion depth of
      right internal jugular vein catheter using Swan-Ganz Continuous Cardiac Output
      Thermodilutioon Cather (Swan-Ganz CCOmbo V).The investigators measure the distance between
      the insertion point and the junction between right atrium and superior vena cava using
      Swan-Ganz CCOmbo V.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 10, 2018</start_date>
  <completion_date type="Actual">December 27, 2019</completion_date>
  <primary_completion_date type="Actual">November 25, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The distance</measure>
    <time_frame>After insertion of the Swan-Ganz Continuous Cardiac Output Thermodilutioon Cather (Swan-Ganz CCOmbo V) and during operation</time_frame>
    <description>The distance between the insertion point and the junction between right atrium and superior vena cava</description>
  </primary_outcome>
  <enrollment type="Actual">105</enrollment>
  <condition>Insertion Depth of Central Venous Catheter</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Swan-Ganz Continuous Cardiac Output Thermodilutioon Cather (Swan-Ganz CCOmbo V)</intervention_name>
    <description>Swan-Ganz CCOmbo V insertion</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for cardiac surgery were studied
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient over 18 years of age undergoing mitral valve or/and tricuspid valve

          -  Surgery under general anesthesia, requiring Swan-Ganz Continuous Cardiac Output
             Thermodilutioon Cather (Swan-Ganz CCOmbo V) insertion through the right internal
             jugular vein.

        Exclusion Criteria:

          -  A change in the mediastinal structure from previous neck surgery,thoracic surgery or
             cardiac surgery

          -  Extracardiac vascular anomaly

          -  Anatomical abnormality in neck and thorax

          -  Refusal to enrol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>qi lu, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diansan Su</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>May 21, 2018</study_first_submitted>
  <study_first_submitted_qc>May 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2018</study_first_posted>
  <last_update_submitted>March 22, 2020</last_update_submitted>
  <last_update_submitted_qc>March 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

